Over-the-counter glucose sensors changed who can buy a diagnostic
A device class built for diabetes management is now a pharmacy purchase for people with no diagnosis. The clearance covers the sensor, not the interpretation.
Home / Oversight and access
Rules and gaps
Access to testing expanded faster than the regulatory frameworks around it. This section follows clearance pathways, enforcement, and the categories operating in unresolved territory.
Newest first. Every piece lists its sources at the foot.
A device class built for diabetes management is now a pharmacy purchase for people with no diagnosis. The clearance covers the sensor, not the interpretation.
Less than most buyers assume. Understanding the actual framework explains most of the strange things on supplement labels.
A large share of the tests sold direct to consumers were never individually reviewed by a regulator. Understanding why explains a lot about the market.
A clinical laboratory report sits inside a chain of professional responsibility. A wellness report frequently does not, and the terms of service usually say so.
Keeps pages loading and remembers this choice. Always on.
Anonymous page counts so we know which articles to update first.
Remembers your sections so the homepage leads with them.